These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 5054587)

  • 21. Influence of disease on binding of drugs to plasma proteins.
    Reidenberg MM; Affrime M
    Ann N Y Acad Sci; 1973 Nov; 226():115-26. PubMed ID: 4520390
    [No Abstract]   [Full Text] [Related]  

  • 22. Use of plasma concentration determinations: phenytoin.
    Adler DS
    Clin Toxicol; 1979; 14(2):147-50. PubMed ID: 436388
    [No Abstract]   [Full Text] [Related]  

  • 23. Reduced in vitro binding of tryptophan by plasma in uremia.
    de Torrente A; Glazer GB; Gulyassy P
    Kidney Int; 1974 Oct; 6(4):222-9. PubMed ID: 4427418
    [No Abstract]   [Full Text] [Related]  

  • 24. In vitro displacement of phenytoin from protein binding by nonsteroidal antiinflammatory drugs tolmetin, ibuprofen, and naproxen in normal and uremic sera.
    Dasgupta A; Timmerman TG
    Ther Drug Monit; 1996 Feb; 18(1):97-9. PubMed ID: 8848829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A major inhibitor of phenytoin binding to serum protein in uremia.
    Mabuchi H; Nakahashi H
    Nephron; 1988; 48(4):310-4. PubMed ID: 3362278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding of digitoxin to human serum proteins: influence of pH on the binding of digitoxin to human albumin.
    Brock A
    Acta Pharmacol Toxicol (Copenh); 1975 Jan; 36(1):13-24. PubMed ID: 238355
    [No Abstract]   [Full Text] [Related]  

  • 27. Altered protein binding of diphenylhydantoin in uremic plasma.
    Blum MR; Riegelman S; Becker CE
    N Engl J Med; 1972 Jan; 286(2):109. PubMed ID: 5006870
    [No Abstract]   [Full Text] [Related]  

  • 28. Sensitive methods for determination of free digitoxin concentration using digitoxin immunoassays: demonstration of elevated free digitoxin concentration caused by digitoxin-phenytoin interaction by applying these new techniques.
    Dasgupta A; Vega AE; Wells A; Datta P
    Ther Drug Monit; 1999 Dec; 21(6):625-30. PubMed ID: 10604823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proceedings: Plasma protein binding and kinetics of diphenylhydantoin in uraemic patients.
    Borga O; Cederlof I
    Acta Pharm Suec; 1974 Dec; 11(6):653-4. PubMed ID: 1136805
    [No Abstract]   [Full Text] [Related]  

  • 30. Uric acid: binding levels of urate ions in normal and uraemic plasma, and in human serum albumin.
    Farrell PC; Ward RA; Hone PW
    Biochem Pharmacol; 1975 Oct; 24(20):1885-7. PubMed ID: 1191338
    [No Abstract]   [Full Text] [Related]  

  • 31. Protein binding of cardiac glycosides in disease states.
    Storstein L
    Clin Pharmacokinet; 1977; 2(3):220-33. PubMed ID: 328208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of ageing on plasma albumin and plasma protein binding of diazepam, salicylic acid and digitoxin in healthy subjects and patients with renal impairment.
    Viani A; Rizzo G; Carrai M; Pacifici GM
    Br J Clin Pharmacol; 1992 Mar; 33(3):299-304. PubMed ID: 1576051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma protein binding in uremia: extraction and characterization of an inhibitor.
    Depner TA; Gulyassy PF
    Kidney Int; 1980 Jul; 18(1):86-94. PubMed ID: 7218662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding of angiotensin I and angiotensin II to plasma proteins precipitated by ammonium sulfate.
    Gordon DB
    Proc Soc Exp Biol Med; 1973 Jan; 142(1):283-8. PubMed ID: 4345721
    [No Abstract]   [Full Text] [Related]  

  • 35. Alteration of plasma albumin in relation to decreased drug binding in uremia.
    Boobis SW
    Clin Pharmacol Ther; 1977 Aug; 22(2):147-53. PubMed ID: 407044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of protein binding on the distribution of 5,5-diphenylhydantoin between plasma and red cells.
    Borondy P; Dill WA; Chang T; Buchanan RA; Glazko AJ
    Ann N Y Acad Sci; 1973 Nov; 226():82-7. PubMed ID: 4520405
    [No Abstract]   [Full Text] [Related]  

  • 37. Digitoxin kinetics in patients with impaired renal function.
    Rasmussen K; Jervell J; Storstein L; Gjerdrum K
    Clin Pharmacol Ther; 1972; 13(1):6-14. PubMed ID: 5008193
    [No Abstract]   [Full Text] [Related]  

  • 38. Uremic sera contain inhibitors that block digitoxin-valproic acid interaction.
    Dasgupta A; Paul A; Wells A
    Am J Med Sci; 2001 Oct; 322(4):204-8. PubMed ID: 11678517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased plasma protein binding of diazoxide in uremia.
    O'Malley K; Velasco M; Pruitt A; McNay JL
    Clin Pharmacol Ther; 1975 Jul; 18(1):53-8. PubMed ID: 1149362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein binding of drugs in uremic and normal serum: the role of endogenous binding inhibitors.
    Sjöholm I; Kober A; Odar-Cederlöf I; Borgåa O
    Biochem Pharmacol; 1976 May; 25(10):1205-13. PubMed ID: 938543
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.